Expression of constitutively activated human c-Kit in Myb transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity

Blood

Volumn 90, Issue 11, 1997, Pages 4539-4552

  Ferrao, Petranel ^a   Gonda, Thomas J ^a   Ashman, Leonie K ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL POPULATION; CELL TRANSFORMATION; DIMERIZATION; HEMATOPOIETIC CELL; HISTIOCYTE; HUMAN; HUMAN CELL; MAST CELL; MONONUCLEAR CELL; ONCOGENE C MYB; POINT MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0030709462     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4539.4539_4539_4552     Document Type: Article

References (43)

1. Yarden Y, Kuang W, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO 6:3341, 1987
2. Lev S, Yarden Y, Givol D: Dimerization and activation of the Kit receptor by monovalent and bivalent binding of stem cell factor. J Biol Chem 267:15970, 1992
3. Rottapel R, Reedijk M, Williams DE, Lyman SD, Anderson DM, Pawson T, Bernstein A: The steel/W transduction pathway: Kit autophosphorylation and its association with a unique subset of cytoplasmic signalling proteins is induced by Steel factor. Mol Cell Biol 11:3043, 1991
4. Ashman LK, Cambareri AC, To LB, Levinzky RJ, Juttner CA: Expression of the YB5.B8 antigen (c-kit proto-oncogene product) in normal human bone marrow. Blood 78:30, 1991
5. Simmons PJ, Aylett GW, Niutta S, To LB, Juttner CA, Ashman LK: c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependem or cytokinesupplemented culture. Exp Hematol 22:157, 1994
6. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
7. Cole SR, Aylett GW, Casey G, Harvey NL, Cambareri AC, Ashman LK: Increased expression of c-Kit or its ligand Steel factor is not a common feature of adult acute myeloid leukaemia. Leukemia 10:288, 1996
8. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield J, Ashman L, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a mast cell leukaemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736, 1993
9. Butterfield J, Weiler D, Dewald G, Gleich G: Establishment of an immature mast cell line from a patient with mast cell leukaemia. Leuk Res 12:345, 1988
10. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Ligand independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83:2619, 1994
11. Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y: Substitution of an aspartic acid in constitutive activation of c-kit receptor tyrosine kinase in rat tumour mast cell line RBL-2H3. Int Arch Allergy Immunol 106:377, 1995
12. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y; Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
13. Hashimoto K, Tsujimura T, Moriyama Y, Yamatodani A, Kimura M, Tohya K, Morimoto M, Kitayama H, Kanakura Y, Kitamura Y: Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine Interleukin-3-dependent cell line. Am J Pathol 148:189, 1996
14. Nagata H, Worobec A, Oh C, Chowdhury B, Tannenbaum S, Susuki Y, Metcalfe D: Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci USA 92:10560, 1995
15. Ikeda H, Kanakura Y, Tamaki T, Kuriu A, Kitayama H, Ishikawa J, Kanayama Y, Yonzawa T, Tarui S, Griffin J: Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemic cells. Blood 78:2962, 1991
16. Kitayama H, Tsujimura T, Matsumura I, Oritani K, Ikeda H, Ishikawa J, Okabe M, Suzuki M, Yamamura K, Matsuzawa Y, Kitamura Y, Kanakura Y: Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995, 1996
17. Sakura H, Kaneii-Ishii C, Nakagoshi H, Gonda TJ, Ishii S: Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA 86:5758, 1989
18. Kanei-Ishii C, Macmillan EM, Nomura T, Sarai A, Ramsay G, Aimoto S, Ishii S, Gonda TJ: Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc Natl Acad Sci USA 89:3088, 1992
19. Gonda TJ: Molecular and cellular activities of Myb: Regulation in normal hemopoiesis and transformation in viral oncogenes Pt. 1. Semin Virol 2:351, 1991
20. Ferrao P, Macmillan EM, Ashman L, Gonda TJ: Enforced expression of full length c-Myb leads to density-dependent transformation of murine hemopoietic cells. Oncogene 11:1631, 1995
21. MacMillan EM, Gonda TJ: Murine myeloid cells transformed by myb require fibroblast-derived or autocrine growth factors in addition to granulocyte-macrophage colony stimulating factor for proliferation. Blood 83:209, 1994
22. Gonda TJ, Macmillan EM, Townsend PV, Hapel AJ: Differentiation state and responses to hematopoietic growth factors of murine myeloid cells transformed by myb. Blood 82:2813, 1993
23. Broxmeyer H, Maze R, Miyazawa K, Carow C, Hendrie PC, Cooper S, Hangoc G, Vadhan-Raj S, Lu L: The Kit receptor and its ligand, Steel factor, as regulators of hemopoiesis. Cancer Cells 3:480, 1991
24. Crosier PS, Ricciardi ST, Hall LR, Vitas MR, Clark SC, Crosier KE: Expression of isoforms of the human receptor tyrosine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 82:1151, 1993
25. Rayner J, Gonda TJ: A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector. Mol Cell Biol 14:880, 1994
26. Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ: Expression of a haemopoietic growth factor cDNA in a factor dependent cell line results in autonomous growth and tumourigenicity. Cell 43:531, 1995
27. Aylett G, Cole SR, Caruana G, Ashman LK: Specificity and functional effects of mAb to c-Kit protein (SCF receptor), in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd, RF (eds): Leucocyte Typing V -White Cell Differentiation Antigens (vol 2). Oxford, UK, Oxford University Press, 1995, p 1917
28. Ashley DM, Bol SJ, Kannourakis G: Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells: Detection of two CD10 positive populations with different proliferative capacities and survival. Leuk Res 18:37, 1994
29. Erber WN, Pinching AJ, Mason DY: Immunocytochemical detection of T and B populations in routine blood smears. Lancet 1:1042,1984
30. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Cytochem Proc 55:283, 1971
31. Lev S, Biechman J, Nishikawa SI, Givol D, Yarden Y: Interspecies molecular chimeras of Kit help define the binding site of the stem cell factor. Mol Cell Biol 13:2224, 1993
32. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119, 1992
33. Metcalf D, Nicola N: Autoinduction of differentiation in WEHI-3B leukemia cells. Int J Cancer 30:773, 1982
34. Moriyama Y, Tsujimura T, Hashimoto K, Morimoto M, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y: Role of aspartic acid 814 in the function and expression of c-kit receptor tyrosine kinase. J Biol Chem 271:3347, 1996
35. Glover H, Baker D, Celetti A, Dibb N: Selection of activating mutations of c-fms in FDC-P1 cells. Oncogene 11:1347, 1995
36. Piao X, Paulson R, van der Geer P, Pawson T, Berstein A: Oncogenic mutation in the Kit receptor alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 93:14665, 1996
37. Paulson R, Vesely S, Siminovitch KA, Berstein A: Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1. Nat Genet 13:309, 1996
38. Yi T, Mui AL, Krystal G, Ihle JN: Hematopoietic cell phosphatase associates with the Interleukin-3 (IL-3) receptor β chain and down-regulates IL-3 induced tyrosine phosphorylation and mitogenesis. Mol Cell Biol 13:7577, 1993
39. Kon-Kozlowski, Pani G, Pawson T, Siminovitch KA: The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem 271:3856, 1996
40. Eckman L, Pragnell IB, Lohler J: Perturbations of multiple hemopoietic lineages in retrovirus-induced murine malignant histiocytosis. Leukemia 9:700, 1995
41. Mayrhofer G, Gadd SJ, Spargo LDJ, Ashman LK: Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues. Immunol Cell Biol 65:241, 1987
42. Laurencet FM, Chapuis B, Roux-Lombard P, Dayer JM, Beris Ph: Malignant histiocytosis in the Leukemic stage: A new entity (M5c-AML) in the FAB Classification? Leukemia 8:502, 1994
43. Esteve J, Rozman M, Campo E, Munoz F, Urbano-Ispizua A, Rozman C: Leukemia after true histiocytic lymphoma: Another type of acute monocytic leukemia with histiocytic differentiation (AML-M5C). Leukemia 9:1389, 1995